Detalles de la búsqueda
1.
Safe co-administration of direct-acting antivirals and direct oral anticoagulants among patients with hepatitis C virus infection: An international multicenter retrospective cohort study.
J Viral Hepat
; 29(12): 1073-1078, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36103593
2.
Drug interactions: a review of the unseen danger of experimental COVID-19 therapies.
J Antimicrob Chemother
; 75(12): 3417-3424, 2020 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32750131
3.
Eight weeks of sofosbuvir/velpatasvir for genotype 3 hepatitis C in previously untreated patients with significant (F2/3) fibrosis.
J Viral Hepat
; 27(4): 371-375, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31756019
4.
Efficacy and safety of glecaprevir/pibrentasvir in patients with chronic HCV infection and psychiatric disorders: An integrated analysis.
J Viral Hepat
; 26(8): 951-960, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30977945
5.
Real-world safety and effectiveness of ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin in hepatitis C virus genotype 1- and 4-infected patients with diverse comorbidities and comedications: A pooled analysis of post-marketing observational studies from 13 countries.
J Viral Hepat
; 26(6): 685-696, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30739368
6.
Ritonavir and COVID-19: pragmatic guidance is important.
Lancet
; 399(10334): 1464-1465, 2022 04 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-35334211
7.
Clinical impact of pharmacokinetic interactions between the HCV protease inhibitor simeprevir and frequently used concomitant medications.
Br J Clin Pharmacol
; 84(5): 961-971, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29345798
8.
Prescribing Nirmatrelvir-Ritonavir: How to Recognize and Manage Drug-Drug Interactions.
Ann Intern Med
; 175(5): 744-746, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35226530
9.
Drug-Drug Interactions With Novel All Oral Interferon-Free Antiviral Agents in a Large Real-World Cohort.
Clin Infect Dis
; 62(5): 561-7, 2016 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26611779
10.
COVID-19 treatment in patients with comorbidities: Awareness of drug-drug interactions.
Br J Clin Pharmacol
; 87(1): 212-213, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32384171
11.
Prevalence of Potentially Clinically Significant Drug-Drug Interactions With Antiretrovirals Against HIV Over Three Decades: A Systematic Review of the Literature.
J Acquir Immune Defic Syndr
; 92(2): 97-105, 2023 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36625857
12.
The Collaborative Care Model: Realizing healthcare values and increasing responsiveness in the pharmacy workforce.
Res Social Adm Pharm
; 19(1): 110-122, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36100521
13.
Are UK pharmacists ready for consultant-level practice? A cross-sectional survey of self-assessed development needs.
Int J Pharm Pract
; 30(6): 559-566, 2022 Dec 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-36047534
14.
Recommendations for the Management of Drug-Drug Interactions Between the COVID-19 Antiviral Nirmatrelvir/Ritonavir (Paxlovid) and Comedications.
Clin Pharmacol Ther
; 112(6): 1191-1200, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35567754
15.
Recommendations for Dosing of Repurposed COVID-19 Medications in Patients with Renal and Hepatic Impairment.
Drugs R D
; 21(1): 9-27, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33336316
16.
Real-World Outcomes in Historically Underserved Patients with Chronic Hepatitis C Infection Treated with Glecaprevir/Pibrentasvir.
Infect Dis Ther
; 10(4): 2203-2222, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34125405
17.
Correction to: Real-World Clinical Practice Use of 8-Week Glecaprevir/Pibrentasvir in Treatment-Naïve Patients with Compensated Cirrhosis.
Adv Ther
; 37(11): 4755-4756, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32915409
18.
Real-World Clinical Practice Use of 8-Week Glecaprevir/Pibrentasvir in Treatment-Naïve Patients with Compensated Cirrhosis.
Adv Ther
; 37(9): 4033-4042, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32754824
19.
Frequency of Potential Drug-Drug Interactions in the Changing Field of HCV Therapy.
Open Forum Infect Dis
; 7(2): ofaa040, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-32104719
20.
Fluvoxamine for the treatment of COVID-19.
Lancet Glob Health
; 10(3): e331, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35180411